These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8476216)

  • 21. Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay.
    Untch M; Sevin BU; Perras JP; Angioli R; Untch A; Hightower RD; Koechli O; Averette HE
    Gynecol Oncol; 1994 Apr; 53(1):44-9. PubMed ID: 7909786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
    Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic potentiation of Cisplatin cytotoxicity by caffeine in a Cisplatin-resistant rat ovarian tumor-cell line.
    Chen G; Zeller W
    Int J Oncol; 1992 Jul; 1(2):129-34. PubMed ID: 21584521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of oridonin and cisplatin on cytotoxicity and DNA cross-link against mouse sarcoma S180 cells in culture.
    Gao ZG; Ye QX; Zhang TM
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):561-4. PubMed ID: 8010060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
    Qin TN; Wang LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
    Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
    Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.
    Ali-Osman F; Srivenugopal K; Berger MS; Stein DE
    Anticancer Res; 1990; 10(3):677-82. PubMed ID: 2164350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein.
    Chen G; Ramachandran C; Krishan A
    Cancer Res; 1993 Jun; 53(11):2544-7. PubMed ID: 8098661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM; Jekunen A; Monni O; Joensuu H; Aebi S; Howell SB; Knuutila S
    Genes Chromosomes Cancer; 1997 Apr; 18(4):286-91. PubMed ID: 9087568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
    Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
    Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.